Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05764174 · ClinicalTrials.gov registry record · NA

Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance

A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
2,409
Enrollment target

NCT05764174: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT05764174 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 2,409 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05764174, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
2,409 participants
Enrollment target

Study Summary

Brief Summary: The main objective of this activity is to assess the effectiveness of different messaging strategies (factual, narrative, mixed and a control) to promote COVID-19 adult vaccination.

Primary Outcome

The participant reports to have been vaccinated against COVID-19 in the last two weeks

Interventions

  • BEHAVIORAL Factual messages
  • BEHAVIORAL Narrative message
  • BEHAVIORAL Mixed message

Trial Details

FieldValue
Enrollment Target 2,409 participants
Start Date 2022-09-21
Est. Completion 2022-12-17
Phase NA

What the finished NCT05764174 record still lists

NCT05764174 is an interventional study that assigns participants to a tested intervention. Its 2,409 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% higher).

The record links to 0 conditions, and to 3 interventions - of which Factual messages is the first listed.

NCT05764174 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05764174 about?

NCT05764174 is a clinical study titled "Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance". Brief Summary: The main objective of this activity is to assess the effectiveness of different messaging strategies (factual, narrative, mixed and a control) to promote COVID-19 adult vaccination.

What is the current status of trial NCT05764174?

This trial is currently completed. It is a NA study. The enrollment target is 2,409 participants. The study started on 2022-09-21. Estimated completion is 2022-12-17.

What interventions are being tested in trial NCT05764174?

The interventions under investigation include: Factual messages (BEHAVIORAL), Narrative message (BEHAVIORAL), Mixed message (BEHAVIORAL).

Who is sponsoring clinical trial NCT05764174?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05764174's enrollment target sits among peer trials

2,409 46th of 2000 higher than 1,955 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05185440 · 2,400 participants · NA

    Reducing Alcohol Involved Sexual Violence in Higher Education

  • NCT05285527 · 2,400 participants · NA

    MiSight 1 Day Safety Post-Approval Study

  • NCT05738330 · 2,400 participants · NA

    Symptom Monitoring in Hemodialysis

  • NCT05833360 · 2,400 participants

    Prospective Study of oncRNA Stratification of Cancer by Size and Stage

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05764174, the US trial registry maintained by the National Library of Medicine. NCT05764174 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.